Alicia Beeghly-Fadiel
Last active: 3/26/2019

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Obesity-Induced Peritoneal Dissemination of Ovarian Cancer and Dominant Recruitment of Macrophages in Ascites. Ignacio RMC, Lee ES, Wilson AJ, Beeghly-Fadiel A, Whalen MM, Son DS (2018) Immune Netw 18(6): e47
    › Primary publication · 30619633 (PubMed) · PMC6312889 (PubMed Central)
  2. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, Butzow R, Campbell IG, Chang-Claude J, Chen K, Cook LS, Cramer DW, deFazio A, Dennis J, Doherty JA, Dörk T, Eccles DM, Edwards DV, Fasching PA, Fortner RT, Gayther SA, Giles GG, Glasspool RM, Goode EL, Goodman MT, Gronwald J, Harris HR, Heitz F, Hildebrandt MA, Høgdall E, Høgdall CK, Huntsman DG, Kar SP, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Koushik A, Lambrechts D, Le ND, Levine DA, Massuger LF, Matsuo K, May T, McNeish IA, Menon U, Modugno F, Monteiro AN, Moorman PG, Moysich KB, Ness RB, Nevanlinna H, Olsson H, Onland-Moret NC, Park SK, Paul J, Pearce CL, Pejovic T, Phelan CM, Pike MC, Ramus SJ, Riboli E, Rodriguez-Antona C, Romieu I, Sandler DP, Schildkraut JM, Setiawan VW, Shan K, Siddiqui N, Sieh W, Stampfer MJ, Sutphen R, Swerdlow AJ, Szafron LM, Teo SH, Tworoger SS, Tyrer JP, Webb PM, Wentzensen N, White E, Willett WC, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Chenevix-Trench G, Sellers TA, Pharoah PDP, Zheng W, Long J (2019) Cancer Res 79(3): 505-517
    › Primary publication · 30559148 (PubMed) · PMC6359948 (PubMed Central)
  3. SMART Cancer Navigator: A Framework for Implementing ASCO Workshop Recommendations to Enable Precision Cancer Medicine. Warner JL, Prasad I, Bennett M, Arniella M, Beeghly-Fadiel A, Mandl KD, Alterovitz G (2018) JCO Precis Oncol
    › Primary publication · 30238071 (PubMed) · PMC6141039 (PubMed Central)
  4. Chemokine Network and Overall Survival in Wild-Type and Mutant Ovarian Cancer. Ignacio RMC, Lee ES, Wilson AJ, Beeghly-Fadiel A, Whalen MM, Son DS (2018) Immune Netw 18(4): e29
    › Primary publication · 30181917 (PubMed) · PMC6117514 (PubMed Central)
  5. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK, Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Benitez J, Bjorge L, Brenton J, Butzow R, Caldes T, Caligo MA, Campbell I, Chang-Claude J, Claes KBM, Couch FJ, Cramer DW, Daly MB, deFazio A, Dennis J, Diez O, Domchek SM, Dörk T, Easton DF, Eccles DM, Fasching PA, Fortner RT, Fountzilas G, Friedman E, Ganz PA, Garber J, Giles GG, Godwin AK, Goldgar DE, Goodman MT, Greene MH, Gronwald J, Hamann U, Heitz F, Hildebrandt MAT, Høgdall CK, Hollestelle A, Hulick PJ, Huntsman DG, Imyanitov EN, Isaacs C, Jakubowska A, James P, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Kwong A, Le ND, Leslie G, Lesueur F, Levine DA, Mattiello A, May T, McGuffog L, McNeish IA, Merritt MA, Modugno F, Montagna M, Neuhausen SL, Nevanlinna H, Nielsen FC, Nikitina-Zake L, Nussbaum RL, Offit K, Olah E, Olopade OI, Olson SH, Olsson H, Osorio A, Park SK, Parsons MT, Peeters PHM, Pejovic T, Peterlongo P, Phelan CM, Pujana MA, Ramus SJ, Rennert G, Risch H, Rodriguez GC, Rodríguez-Antona C, Romieu I, Rookus MA, Rossing MA, Rzepecka IK, Sandler DP, Schmutzler RK, Setiawan VW, Sharma P, Sieh W, Simard J, Singer CF, Song H, Southey MC, Spurdle AB, Sutphen R, Swerdlow AJ, Teixeira MR, Teo SH, Thomassen M, Tischkowitz M, Toland AE, Trichopoulou A, Tung N, Tworoger SS, van Rensburg EJ, Vanderstichele A, Vega A, Edwards DV, Webb PM, Weitzel JN, Wentzensen N, White E, Wolk A, Wu AH, Yannoukakos D, Zorn KK, Gayther SA, Antoniou AC, Berchuck A, Goode EL, Chenevix-Trench G, Sellers TA, Pharoah PDP, Zheng W, Long J (2018) Cancer Res 78(18): 5419-5430
    › Primary publication · 30054336 (PubMed) · PMC6139053 (PubMed Central)
  6. Gene expression in triple-negative breast cancer in relation to survival. Wang S, Beeghly-Fadiel A, Cai Q, Cai H, Guo X, Shi L, Wu J, Ye F, Qiu Q, Zheng Y, Zheng W, Bao PP, Shu XO (2018) Breast Cancer Res Treat 171(1): 199-207
    › Primary publication · 29748761 (PubMed)
  7. Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors. Beeghly-Fadiel A, Wilson AJ, Keene S, El Ramahi M, Xu S, Marnett LJ, Fadare O, Crispens MA, Khabele D (2018) J Ovarian Res 11(1): 17
    › Primary publication · 29482584 (PubMed) · PMC5828488 (PubMed Central)
  8. Blood type, ABO genetic variants, and ovarian cancer survival. Cozzi GD, Levinson RT, Toole H, Snyder MR, Deng A, Crispens MA, Khabele D, Beeghly-Fadiel A (2017) PLoS One 12(4): e0175119
    › Primary publication · 28448592 (PubMed) · PMC5407760 (PubMed Central)
  9. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Australian Ovarian Cancer Study Group, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Ness RB, Edwards RP, Jensen A, Kjær SK, Høgdall E, Berchuck A, Cramer DW, Terry KL, Poole EM, Bandera EV, Paddock LE, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Pike MC, Webb PM (2017) Br J Cancer 116(9): 1223-1228
    › Primary publication · 28350790 (PubMed) · PMC5418444 (PubMed Central)
  10. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. Guo Y, Warren Andersen S, Shu XO, Michailidou K, Bolla MK, Wang Q, Garcia-Closas M, Milne RL, Schmidt MK, Chang-Claude J, Dunning A, Bojesen SE, Ahsan H, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bogdanova NV, Bonanni B, Børresen-Dale AL, Brand J, Brauch H, Brenner H, Brüning T, Burwinkel B, Casey G, Chenevix-Trench G, Couch FJ, Cox A, Cross SS, Czene K, Devilee P, Dörk T, Dumont M, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fostira F, Gammon M, Giles GG, Guénel P, Haiman CA, Hamann U, Hooning MJ, Hopper JL, Jakubowska A, Jasmine F, Jenkins M, John EM, Johnson N, Jones ME, Kabisch M, Kibriya M, Knight JA, Koppert LB, Kosma VM, Kristensen V, Le Marchand L, Lee E, Li J, Lindblom A, Luben R, Lubinski J, Malone KE, Mannermaa A, Margolin S, Marme F, McLean C, Meijers-Heijboer H, Meindl A, Neuhausen SL, Nevanlinna H, Neven P, Olson JE, Perez JI, Perkins B, Peterlongo P, Phillips KA, Pylkäs K, Rudolph A, Santella R, Sawyer EJ, Schmutzler RK, Seynaeve C, Shah M, Shrubsole MJ, Southey MC, Swerdlow AJ, Toland AE, Tomlinson I, Torres D, Truong T, Ursin G, Van Der Luijt RB, Verhoef S, Whittemore AS, Winqvist R, Zhao H, Zhao S, Hall P, Simard J, Kraft P, Pharoah P, Hunter D, Easton DF, Zheng W (2016) PLoS Med 13(8): e1002105
    › Primary publication · 27551723 (PubMed) · PMC4995025 (PubMed Central)
  11. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records. Cozzi GD, Samuel JM, Fromal JT, Keene S, Crispens MA, Khabele D, Beeghly-Fadiel A (2016) BMC Cancer : 612
    › Primary publication · 27502272 (PubMed) · PMC4977858 (PubMed Central)
  12. Early onset pancreatic malignancies: Clinical characteristics and survival associations. Beeghly-Fadiel A, Luu HN, Du L, Shi C, McGavic DP, Parikh AA, Raskin L (2016) Int J Cancer 139(10): 2169-77
    › Primary publication · 27416564 (PubMed)
  13. Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years. Huang Z, Zheng Y, Wen W, Wu C, Bao P, Wang C, Zhong W, Gao YT, Jin F, Xiang YB, Shu XO, Beeghly-Fadiel A (2016) Eur J Cancer : 1-10
    › Primary publication · 27254837 (PubMed) · PMC4942399 (PubMed Central)
  14. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, Shu XO, Schmidt MK, Milne RL, García-Closas M, Chang-Claude J, Lindstrom S, Bojesen SE, Ahsan H, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadiel A, Benitez J, Blomqvist C, Bogdanova NV, Børresen-Dale AL, Brand J, Brauch H, Brenner H, Burwinkel B, Cai Q, Casey G, Chenevix-Trench G, Couch FJ, Cox A, Cross SS, Czene K, Dörk T, Dumont M, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fostira F, Gammon M, Giles GG, Guénel P, Haiman CA, Hamann U, Harrington P, Hartman M, Hooning MJ, Hopper JL, Jakubowska A, Jasmine F, John EM, Johnson N, Kabisch M, Khan S, Kibriya M, Knight JA, Kosma VM, Kriege M, Kristensen V, Le Marchand L, Lee E, Li J, Lindblom A, Lophatananon A, Luben R, Lubinski J, Malone KE, Mannermaa A, Manoukian S, Margolin S, Marme F, McLean C, Meijers-Heijboer H, Meindl A, Miao H, Muir K, Neuhausen SL, Nevanlinna H, Neven P, Olson JE, Perkins B, Peterlongo P, Phillips KA, Pylkäs K, Rudolph A, Santella R, Sawyer EJ, Schmutzler RK, Schoemaker M, Shah M, Shrubsole M, Southey MC, Swerdlow AJ, Toland AE, Tomlinson I, Torres D, Truong T, Ursin G, Van Der Luijt RB, Verhoef S, Wang-Gohrke S, Whittemore AS, Winqvist R, Pilar Zamora M, Zhao H, Dunning AM, Simard J, Hall P, Kraft P, Pharoah P, Hunter D, Easton DF, Zheng W (2016) Cancer Causes Control 27(5): 679-93
    › Primary publication · 27053251 (PubMed) · PMC5029371 (PubMed Central)
  15. Breast cancer incidence and mortality: trends over 40 years among women in Shanghai, China. Huang Z, Wen W, Zheng Y, Gao YT, Wu C, Bao P, Wang C, Gu K, Peng P, Gong Y, Zhang M, Xiang Y, Zhong W, Jin F, Xiang YB, Shu XO, Beeghly-Fadiel A (2016) Ann Oncol 27(6): 1129-34
    › Primary publication · 27013394 (PubMed) · PMC4880061 (PubMed Central)
  16. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium. Lei J, Rudolph A, Moysich KB, Behrens S, Goode EL, Bolla MK, Dennis J, Dunning AM, Easton DF, Wang Q, Benitez J, Hopper JL, Southey MC, Schmidt MK, Broeks A, Fasching PA, Haeberle L, Peto J, Dos-Santos-Silva I, Sawyer EJ, Tomlinson I, Burwinkel B, Marmé F, Guénel P, Truong T, Bojesen SE, Flyger H, Nielsen SF, Nordestgaard BG, González-Neira A, Menéndez P, Anton-Culver H, Neuhausen SL, Brenner H, Arndt V, Meindl A, Schmutzler RK, Brauch H, Hamann U, Nevanlinna H, Fagerholm R, Dörk T, Bogdanova NV, Mannermaa A, Hartikainen JM, Australian Ovarian Study Group, kConFab Investigators, Van Dijck L, Smeets A, Flesch-Janys D, Eilber U, Radice P, Peterlongo P, Couch FJ, Hallberg E, Giles GG, Milne RL, Haiman CA, Schumacher F, Simard J, Goldberg MS, Kristensen V, Borresen-Dale AL, Zheng W, Beeghly-Fadiel A, Winqvist R, Grip M, Andrulis IL, Glendon G, García-Closas M, Figueroa J, Czene K, Brand JS, Darabi H, Eriksson M, Hall P, Li J, Cox A, Cross SS, Pharoah PD, Shah M, Kabisch M, Torres D, Jakubowska A, Lubinski J, Ademuyiwa F, Ambrosone CB, Swerdlow A, Jones M, Chang-Claude J (2016) Hum Genet 135(1): 137-54
    › Primary publication · 26621531 (PubMed) · PMC4698282 (PubMed Central)
  17. Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer. Wilson AJ, Fadare O, Beeghly-Fadiel A, Son DS, Liu Q, Zhao S, Saskowski J, Uddin MJ, Daniel C, Crews B, Lehmann BD, Pietenpol JA, Crispens MA, Marnett LJ, Khabele D (2015) Oncotarget 6(25): 21353-68
    › Primary publication · 25972361 (PubMed) · PMC4673270 (PubMed Central)
  18. Energy-Related Indicators and Breast Cancer Risk among White and Black Women. Sanderson M, Lipworth L, Shen-Miller D, Nechuta S, Beeghly-Fadiel A, Shrubsole MJ, Zheng W (2015) PLoS One 10(4): e0125058
    › Primary publication · 25927530 (PubMed) · PMC4416034 (PubMed Central)
  19. Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study. Huang Z, Gao Y, Wen W, Li H, Zheng W, Shu XO, Beeghly-Fadiel A (2015) Int J Cancer 137(3): 607-14
    › Primary publication · 25556333 (PubMed) · PMC4437849 (PubMed Central)
  20. Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk. Xi J, Su Y, Beeghly Fadiel A, Lin Y, Su FX, Jia WH, Tang LY, Ren ZF (2014) Cancer Epidemiol 38(6): 708-14
    › Primary publication · 25270516 (PubMed)
  21. Mammography use among women with and without diabetes: results from the Southern Community Cohort Study. Sanderson M, Lipworth L, Han X, Beeghly-Fadiel A, Shen-Miller D, Patel K, Blot WJ, Hargreaves MK (2014) J Epidemiol Glob Health 4(3): 223-30
    › Primary publication · 25107658 (PubMed) · PMC4129367 (PubMed Central)
  22. Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women. Cui Y, Deming-Halverson SL, Shrubsole MJ, Beeghly-Fadiel A, Cai H, Fair AM, Shu XO, Zheng W (2014) Breast Cancer Res Treat 146(2): 439-46
    › Primary publication · 24986698 (PubMed) · PMC4130355 (PubMed Central)
  23. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women. Cui Y, Deming-Halverson SL, Shrubsole MJ, Beeghly-Fadiel A, Fair AM, Sanderson M, Shu XO, Kelley MC, Zheng W (2014) Clin Breast Cancer 14(6): 417-25
    › Primary publication · 24970715 (PubMed) · PMC4253543 (PubMed Central)
  24. Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk. Cui Y, Deming-Halverson SL, Beeghly-Fadiel A, Lipworth L, Shrubsole MJ, Fair AM, Shu XO, Zheng W (2014) Clin Cancer Res 20(5): 1169-78
    › Primary publication · 24423614 (PubMed) · PMC3972811 (PubMed Central)
  25. Associations of reproductive time events and intervals with breast cancer risk: a report from the Shanghai Breast Cancer Study. Huang Z, Beeghly-Fadiel A, Gao YT, Zheng Y, Dai Q, Lu W, Zheng W, Shu XO (2014) Int J Cancer 135(1): 186-95
    › Primary publication · 24323821 (PubMed) · PMC4591050 (PubMed Central)
  26. Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women's Health Study. Ma X, Beeghly-Fadiel A, Shu XO, Li H, Yang G, Gao YT, Zheng W (2013) Br J Cancer 109(3): 751-5
    › Primary publication · 23860524 (PubMed) · PMC3738128 (PubMed Central)
  27. No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women. Dorjgochoo T, Zheng Y, Gao YT, Ma X, Long J, Bao P, Zhang B, Wen W, Lu W, Zheng W, Shu XO, Beeghly-Fadiel A (2013) Cancer Epidemiol 37(5): 619-24
    › Primary publication · 23850146 (PubMed) · PMC4064366 (PubMed Central)
  28. Evaluation of GWAS-identified genetic variants for age at menarche among Chinese women. Delahanty RJ, Beeghly-Fadiel A, Long JR, Gao YT, Lu W, Xiang YB, Zheng Y, Ji BT, Wen WQ, Cai QY, Zheng W, Shu XO (2013) Hum Reprod 28(4): 1135-43
    › Primary publication · 23406970 (PubMed) · PMC3600840 (PubMed Central)
  29. No association between ovarian cancer susceptibility variants and breast cancer risk among Chinese women. Ma X, Cai Q, Delahanty RJ, Shu XO, Zhang B, Lu W, Gao YT, Zheng W, Long J, Beeghly-Fadiel A (2013) Cancer Epidemiol Biomarkers Prev 22(3): 467-9
    › Primary publication · 23292081 (PubMed) · PMC3596432 (PubMed Central)
  30. Gene-environment interactions for breast cancer risk among Chinese women: a report from the Shanghai Breast Cancer Genetics Study. Li H, Beeghly-Fadiel A, Wen W, Lu W, Gao YT, Xiang YB, Cai Q, Long J, Shi J, Chen K, Zheng Y, Shu XO, Zheng W (2013) Am J Epidemiol 177(2): 161-70
    › Primary publication · 23221726 (PubMed) · PMC3590035 (PubMed Central)
  31. Polymorphisms in inflammation pathway genes and endometrial cancer risk. Delahanty RJ, Xiang YB, Spurdle A, Beeghly-Fadiel A, Long J, Thompson D, Tomlinson I, Yu H, Lambrechts D, Dörk T, Goodman MT, Zheng Y, Salvesen HB, Bao PP, Amant F, Beckmann MW, Coenegrachts L, Coosemans A, Dubrowinskaja N, Dunning A, Runnebaum IB, Easton D, Ekici AB, Fasching PA, Halle MK, Hein A, Howarth K, Gorman M, Kaydarova D, Krakstad C, Lose F, Lu L, Lurie G, O'Mara T, Matsuno RK, Pharoah P, Risch H, Corssen M, Trovik J, Turmanov N, Wen W, Lu W, Cai Q, Zheng W, Shu XO (2013) Cancer Epidemiol Biomarkers Prev 22(2): 216-23
    › Primary publication · 23221126 (PubMed) · PMC3677562 (PubMed Central)
  32. Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians. Ma X, Beeghly-Fadiel A, Lu W, Shi J, Xiang YB, Cai Q, Shen H, Shen CY, Ren Z, Matsuo K, Khoo US, Iwasaki M, Long J, Zhang B, Ji BT, Zheng Y, Wang W, Hu Z, Liu Y, Wu PE, Shieh YL, Wang S, Xie X, Ito H, Kasuga Y, Chan KY, Iwata H, Tsugane S, Gao YT, Shu XO, Moses HL, Zheng W (2012) Cancer Epidemiol Biomarkers Prev 21(7): 1176-84
    › Primary publication · 22539603 (PubMed) · PMC3810157 (PubMed Central)
  33. Replication study for reported SNP associations with breast cancer survival. Beeghly-Fadiel A, Zheng W, Lu W, Long J, Zheng Y, Cai H, Gu K, Chen Z, Cai Q, Gao YT, Shu XO (2012) J Cancer Res Clin Oncol 138(6): 1019-26
    › Primary publication · 22367361 (PubMed) · PMC3810152 (PubMed Central)
  34. Melatonin pathway genes and breast cancer risk among Chinese women. Deming SL, Lu W, Beeghly-Fadiel A, Zheng Y, Cai Q, Long J, Shu XO, Gao YT, Zheng W (2012) Breast Cancer Res Treat 132(2): 693-9
    › Primary publication · 22138747 (PubMed) · PMC3777385 (PubMed Central)
  35. Association of obesity-related genetic variants with endometrial cancer risk: a report from the Shanghai Endometrial Cancer Genetics Study. Delahanty RJ, Beeghly-Fadiel A, Xiang YB, Long J, Cai Q, Wen W, Xu WH, Cai H, He J, Gao YT, Zheng W, Shu XO (2011) Am J Epidemiol 174(10): 1115-26
    › Primary publication · 21976109 (PubMed) · PMC3246689 (PubMed Central)
  36. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011) Lancet Oncol 12(5): 477-88
    › Primary publication · 21514219 (PubMed) · PMC3114278 (PubMed Central)
  37. Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study. Zhang B, Beeghly-Fadiel A, Lu W, Cai Q, Xiang YB, Zheng Y, Long J, Ye C, Gu K, Shu XO, Gao Y, Zheng W (2011) Am J Epidemiol 173(10): 1159-70
    › Primary publication · 21454829 (PubMed) · PMC3121323 (PubMed Central)
  38. Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Beeghly-Fadiel A, Shu XO, Lu W, Long J, Cai Q, Xiang YB, Zheng Y, Zhao Z, Gu K, Gao YT, Zheng W (2011) Cancer Epidemiol Biomarkers Prev 20(1): 33-41
    › Primary publication · 21119072 (PubMed) · PMC3336364 (PubMed Central)
  39. IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics. Qian B, Katsaros D, Lu L, Canuto EM, Benedetto C, Beeghly-Fadiel A, Yu H (2011) Oncol Rep 25(1): 203-13
    › Primary publication · 21109978 (PubMed) · PMC3075064 (PubMed Central)
  40. MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Beeghly-Fadiel A, Lu W, Shu XO, Long J, Cai Q, Xiang Y, Gao YT, Zheng W (2011) Breast Cancer Res Treat 126(2): 507-13
    › Primary publication · 20725776 (PubMed) · PMC3345163 (PubMed Central)
  41. E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study. Beeghly-Fadiel A, Lu W, Gao YT, Long J, Deming SL, Cai Q, Zheng Y, Shu XO, Zheng W (2010) Breast Cancer Res Treat 121(2): 445-52
    › Primary publication · 19834798 (PubMed) · PMC2874636 (PubMed Central)
  42. Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility. Beeghly-Fadiel A, Lu W, Long JR, Shu XO, Zheng Y, Cai Q, Gao YT, Zheng W (2009) Cancer Epidemiol Biomarkers Prev 18(6): 1770-6
    › Primary publication · 19454611 (PubMed) · PMC2747044 (PubMed Central)
  43. No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk. Beeghly-Fadiel A, Xiang YB, Deming SL, Long JR, Xu WH, Cai Q, Zheng W, Shu XO (2009) Cancer Epidemiol Biomarkers Prev 18(6): 1925-8
    › Primary publication · 19435861 (PubMed) · PMC2770800 (PubMed Central)
  44. Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival. Peterson NB, Beeghly-Fadiel A, Gao YT, Long J, Cai Q, Shu XO, Zheng W (2009) Int J Cancer 125(4): 844-50
    › Primary publication · 19431211 (PubMed) · PMC2745995 (PubMed Central)
  45. No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study. Beeghly-Fadiel A, Cai Q, Lu W, Long J, Gao YT, Shu XO, Zheng W (2009) Cancer Epidemiol Biomarkers Prev 18(4): 1324-7
    › Primary publication · 19318431 (PubMed) · PMC2701308 (PubMed Central)
  46. Genetic polymorphisms in the MMP-7 gene and breast cancer survival. Beeghly-Fadiel A, Shu XO, Long J, Li C, Cai Q, Cai H, Gao YT, Zheng W (2009) Int J Cancer 124(1): 208-14
    › Primary publication · 18798254 (PubMed) · PMC2597698 (PubMed Central)
  47. Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality. Beeghly-Fadiel A, Long JR, Gao YT, Li C, Qu S, Cai Q, Zheng Y, Ruan ZX, Levy SE, Deming SL, Snoddy JR, Shu XO, Lu W, Zheng W (2008) Cancer Res 68(15): 6453-9
    › Primary publication · 18648013 (PubMed) · PMC2718434 (PubMed Central)
  48. Her-2/neu amplification and breast cancer survival: results from the Shanghai breast cancer study. Beeghly-Fadiel A, Kataoka N, Shu XO, Cai Q, Deming SL, Gao YT, Zheng W (2008) Oncol Rep 19(5): 1347-54
    › Primary publication · 18425397 (PubMed) · PMC6519112 (PubMed Central)
  49. IGF-II promoter methylation and ovarian cancer prognosis. Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ, Yu H (2007) J Cancer Res Clin Oncol 133(10): 713-23
    › Primary publication · 17569086 (PubMed)
  50. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H (2006) Cancer 107(2): 299-308
    › Primary publication · 16773633 (PubMed)
  51. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu H (2006) Gynecol Oncol 100(2): 330-7
    › Primary publication · 16199080 (PubMed)
  52. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, Soler-Vila H, Beeghly A, Duan F, Owens P (2004) Cancer 101(6): 1293-301
    › Primary publication · 15368321 (PubMed)
  53. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Park HL, Bai C, Platt KA, Matise MP, Beeghly A, Hui CC, Nakashima M, Joyner AL (2000) Development 127(8): 1593-605
    › Primary publication · 10725236 (PubMed)
  54. Toward the construction of integrated physical and genetic maps of the mouse genome using interspersed repetitive sequence PCR (IRS-PCR) genomics. Hunter KW, Riba L, Schalkwyk L, Clark M, Resenchuk S, Beeghly A, Su J, Tinkov F, Lee P, Ramu E, Lehrach H, Housman D (1996) Genome Res 6(4): 290-9
    › Primary publication · 8723722 (PubMed)